NSETrading Plan under PIT30 Sept 2026 · 30 Sept 2026, 05:19 pm
Trading Plan under PIT
Medicamen Biotech Limited · MEDICAMEQ
✦ AI SummaryRelated Party
Medicamen Biotech Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, disclosing a sale of 70,000 equity shares by Director Sanjay Bansal.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medicamen Biotech Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDICAMEQ_30092026171905_3051_001.pdf
View document text
FORM C
SEBI (Prohibition of Insider Trading) Regulations, 2015
[Regulation 7 (2) read with Regulation 6(2) – Continual disclosure]
Name of the company: Medicamen Biotech Limited
ISIN of the company: INE646B01010
Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).
Name, Category of Securities held Securities acquired/Disposed Securities held post Date of allotment Date of Mode of
PAN, Person prior to acquisition/disposal advice/ intimation acquisition /
CIN/DIN, (Promoters/ acquisition/disposal acquisition of to disposal (on
& address KMP / shares/ company market/public
with Directors/ sale of shares /
contact immediate specify rights/
nos. Relative preferential
to/others offer / off
Type of No. Type of No. Value (In Transact Type of No. and % From To
etc.) and % market/ Inter-
security security Rs.) ion security of
of se
(For eg. Type (For eg.– shareholdin
shareholdi (For eg.– transfer,
–Shares, ng Shares, (Buy/ Shares, g
ESOPs
Warrants, Warrants, Sale/ Warrants,
etc.)
Convertible Pledge / Convertib
Convertibl
Debentures e Revoke/ le
etc.) Debenture Invoke) Debenture
s etc.) s etc.)
Name: Sanjay Director Equity shares 1,02,813 Equity 32,813 1,05,42,440 Sale Equity 70,000 (0.51) 28.09.2026 30.09.2026 30.09.2026 On market
Bansal S/o Late Equity Shares Equity Shares (One Crore Shares
Mr. Kedar Nath Shares Five Lakhs
0.76% Forty-Two
PAN: Thousand
AELPB1342K Four
Hundred and
Address: House
Forty)
No. 5, First
Floor, Road No.-
65, Punjabi Bagh
West, New
Delhi- 110026
Contact No.:
+919810061262
E-mail:
sbansalindia@ya
hoo.com
Note: “Securities” shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and othersuch persons as mentioned in Regulation 6(2).
Exchange on which
Trading in derivatives (Specify type of contract, Futures or Options etc) thetrade was
executed
Buy Sell
Type of Contract Number of units
Number of units
contract specifications Notional Value (contracts * lot Notional Value
(contracts * lot size)
size)
NA NA NA NA NA NA NA
Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options.
Yours faithfully
Sanjay Bansal
Director
DIN: 00121667
Date: 30.09.2026
Place: New Delhi
******